Warning: Table './metrobus_MBM/sessions' is marked as crashed and should be repaired query: DELETE FROM sessions WHERE timestamp < 1490426014 in /home/metrobus/public_html/includes/database.mysql.inc on line 136

Warning: Cannot modify header information - headers already sent by (output started at /home/metrobus/public_html/includes/database.mysql.inc:136) in /home/metrobus/public_html/includes/bootstrap.inc on line 726

Warning: Cannot modify header information - headers already sent by (output started at /home/metrobus/public_html/includes/database.mysql.inc:136) in /home/metrobus/public_html/includes/bootstrap.inc on line 727

Warning: Cannot modify header information - headers already sent by (output started at /home/metrobus/public_html/includes/database.mysql.inc:136) in /home/metrobus/public_html/includes/bootstrap.inc on line 728

Warning: Cannot modify header information - headers already sent by (output started at /home/metrobus/public_html/includes/database.mysql.inc:136) in /home/metrobus/public_html/includes/bootstrap.inc on line 729
Content about Gaithersburg | Metro Business Media
Share |

Content about Gaithersburg

warning: Cannot modify header information - headers already sent by (output started at /home/metrobus/public_html/includes/database.mysql.inc:136) in /home/metrobus/public_html/includes/common.inc on line 148.
August 9, 2011

Stella went into the hospital with a pain so great it cripples her entire being.  “It feels like a stabbing needle pain that shoots through my joints” she said.  No longer able to carry on her day to day routine she finally gives in after a few pills of over-the-counter pain medication did not work, and heads to the emergency room.  Her body is used to taking high doses of pain medication to alleviate the pain, so no regular pill will work.  The doctors and nurses in the hospital are too familiar with the patient; the only

August 14, 2015

Fresh off winning a $20 million Ebola treatment contract from the Department of Health and Human Services, Gaithersburg, Md.-based Emergent BioSolutions (NYSE: EBS) has been awarded another contract, this time from Centers for Disease Control and Prevention (CDC).

The biodefense company announced that the CDC has exercised an option to increase its supply of Vaccinia Immune Globulin (VIGIV), a smallpox vaccine.

July 31, 2015

The Gaithersburg, Md.-based biotech that came up with a faster and innovative way to produce vaccines has announced positive data from a Phase 2 trial focused on developing an Influenza vaccine.

March 21, 2014

Washington, D.C.-based Vanda Pharmaceuticals Inc (NASDAQ:VNDA), has launched a couple of drugs and even recently put into place a television ad campaign. The company is now in need of extra space and will expand into an additional 8,600 square feet at its D.C. headquarters located at 2200 Pennsylvania Avenue.

Vanda will pay the landlord, Square 54 Office Owner LLC, and additional $381,000 for a 12 year and one month term lease beginning on September 1, 2014, although Vanda will get a nine month grace period.

March 13, 2014

In late 2012 Sucampo Pharmaceuticals (NASDAQ: SCMP) received approval from the Food and Drug Administration (FDA)  to expand upon its gastrointestinal drug -- AMITIZA -- to treat people with opioid-induced constipation (OIC) in the United States.

With increasing competition from other biotechnology companies, that approval is keeping the Bethesda-based drug developer ahead of them and profitable, with a net income posted in 3 out of the last 4 quarters of 2013, including the most recent fourth quarter.

March 13, 2014

Germantown, Maryland-based Intrexon Corporation (NYSE:XON) stock was recently upgraded by EVA Dimensions last week but that doesn’t explain yesterdays price surge of more than 10 percent for the company.

Intrexon was the third most price-trending stock on Google Finance yesterday, the stock price of the company increased more than 11.46 percent (+ $3.14) to close at $30.55 per share.

A few reasons that could have driven Intrexon’s stock price higher,

March 13, 2014

In late 2012 Sucampo Pharmaceuticals (NASDAQ: SCMP) received approval from the Food and Drug Administration (FDA)  to expand upon its gastrointestinal drug -- AMITIZA -- to treat people with opioid-induced constipation (OIC) in the United States.

With increasing competition from other biotechnology companies, that approval is keeping the Bethesda-based drug developer ahead of them and profitable, with a net income posted in 3 out of the last 4 quarters of 2013, including the most recent fourth quarter.

March 6, 2014

Silver Spring-based United Therapeutics (NASDAQ: UTHR) finished off 2013 with a strong showing, collecting revenues of over $1.1 billion for the first time in its corporate history as well posting a net profit for the full-year 2013 and upbeat 2014 outlook.

February 28, 2014

Silver Spring, Maryland-based United Therapeutics Corporation (NASDAQ:UTHR) crossed well over $1 billion in revenue for the first time in its corporate history and according to CEO Martine Rothblatt J.D., Ph.D., 2014 will be an even better year.

February 28, 2014

Shareholders of Gaithersburg, Maryland-based GlycoMimetics Inc (NASDAQ:GLYC) are already enjoying 42 percent gains after the company went public in January. The stock started off at $8 per share and has climbed to a high of $13.37, achieved only yesterday.

There’s some speculation as to why the stock price jumped 21 percent on February 25th, rumors range from short interest to major news on the way.